Cancer Treatment News and Research

RSS

Enzalutamide shows promise in treating triple-negative and estrogen-positive breast cancer

Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer treatment options - this aggressive form of breast cancer without ER, PR or HER2, which was thought not to be driven by hormones, is known as triple negative.

3 Dec 2012

Scientists determine how two proteins help create organelles

Scientists at The Scripps Research Institute (TSRI) have determined how two proteins help create organelles, or specialized subunits within a cell, that play a vital role in maintaining cell health. This discovery opens the door for research on substances that could interfere with the formation of these organelles and lead to new therapies for cancer.

2 Dec 2012

Weak economic situation will affect health of ageing population, researchers warn

Many people will be much poorer than they had expected in their older age and this has profound implications for the health of our ageing population claims an editorial published today in Age & Ageing, the scientific journal of the British Geriatrics Society.

1 Dec 2012

Delaying treatment affects mortality rates among women with breast cancer

Results from a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) show women who wait more than 60 days to begin treatment for advanced breast cancer face significantly higher risks of dying than women who start therapy shortly after diagnosis.

30 Nov 2012

Rural cancer survivors more likely to have poor health outcomes

Cancer survivors who live in rural areas are more likely to say they are in poor health than those who live in urban areas, according to a study in the journal Cancer. They are also more likely to have other health disorders, more psychological distress, and be unemployed due to health reasons than city dwellers.

30 Nov 2012

Diabetes education critical for uncontrolled high blood sugar people with cancer

When people with Type 2 diabetes are diagnosed with cancer -- a disease for which they are at higher risk -- they ignore their diabetes care to focus on cancer treatment, according to new Northwestern Medicine- research. But uncontrolled high blood sugar is more likely to kill them and impairs their immune system's ability to fight cancer.

30 Nov 2012

New detection method can identify genetic switches associated with breast cancer

Physicians may now be better at detecting breast cancer than ever before, but much more work remains to ensure accurate diagnosis is possible and especially to assess future risk. That's why researchers from Germany have been working to develop a new test of gene action to predict cancer risk both at first diagnosis and into the future.

30 Nov 2012

Disabling ItpkB enzyme improves function of Natural Killer cells

Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease defense: the body's immune system. By revealing a novel but widespread cell signaling process, the scientists may have found a way to manipulate an important component of the immune system into more effectively fighting disease.

29 Nov 2012

Cancer-related fatigue and exercise: an interview with Dr Fiona Cramp

It is likely that there is more than one reason why people with cancer experience fatigue. The causes are likely to include side effects of the treatment that people are receiving for cancer as well as the direct effects of the cancer.

28 Nov 2012

Contralateral prophylactic mastectomy does not reduce breast cancer recurrence

About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds.

28 Nov 2012

Study examines reasons why smoking is not treated in many cancer patients

It's a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.

27 Nov 2012

Chemotherapy can induce brain changes that may affect concentration and memory

Chemotherapy can induce changes in the brain that may affect concentration and memory, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

27 Nov 2012

Roundup: Abortion opponents see openings in Ark., Wis.; Dems look to upend Maine GOP health law; Rural health care issues in Texas, Kansas

Abortion opponents in Arkansas see an opportunity to enact new restrictions, including a ban on the use of telemedicine to make the abortion pill available, with Republicans controlling both sides of the Legislature in next year's session. Fresh off an election where Republicans won control of the state House and Senate for the first time in 138 years, GOP lawmakers and anti-abortion groups are now focusing on a handful of bills they believe have a better chance.

26 Nov 2012

Two new studies explore how laws, advertising impact cancer costs

Reuters reports on two new studies regarding cancer treatment costs, including findings that laws don't curb the use of pricey prostate cancer treatments and that ads don't increase the use of aromatase inhibitors for breast cancer.

26 Nov 2012

BSD-2000 Hyperthermia System purchased by Cancer Treatment Centers of America

BSD Medical Corporation, a leading provider of medical systems that utilize targeted heat therapy to treat cancer, announced today that the Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (WRMC), located in Goodyear, Arizona, has purchased a BSD-2000 Hyperthermia System (BSD-2000).

26 Nov 2012